Ticker Details
Harrow Health, Inc. Common Stock
IPO Date:	October 1, 2007
Sector:	Healthcare
Industry:	Drug Manufacturers
Market Cap:	$1.93B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.53 | 2.72%
Avg Daily Range (30 D):	$0.96 | 2.02%
Avg Daily Range (90 D):	$1.13 | 2.60%

Institutional Daily Volume
Avg Daily Volume:	.33M
Avg Daily Volume (30 D):	.44M
Avg Daily Volume (90 D):	.52M

Trade Size
Avg Trade Size (Sh.):	65
Avg Trade Size (Sh.) (30 D):	47
Avg Trade Size (Sh.) (90 D):	49

Institutional Trades
Total Institutional Trades:	808
Avg Institutional Trade:	$1.75M
Avg Institutional Trade (30 D):	$1.8M
Avg Institutional Trade (90 D):	$1.75M
Avg Institutional Trade Volume:	.07M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.96M
Avg Closing Trade (30 D):	$2.2M
Avg Closing Trade (90 D):	$2.14M
Avg Closing Volume:	70.13K

News

Feb 18, 2026 @ 12:00 PM Harrow To Report Fourth Quarter and Year-End 2025 ... Source: Na

Feb 2, 2026 @ 12:00 PM Harrow Reaffirms 2025 Full-Year Revenue Guidance o... Source: Na

Nov 27, 2025 @ 3:15 PM Penn Capital Unwinds $17.1 Million BGC Stake as Br... Source: Jonathan Ponciano

Sep 26, 2025 @ 12:57 PM Could Harrow's New Sedation Pill Change Millions O... Source: Triveni Kothapalli

Sep 26, 2025 @ 11:00 AM Harrow to Acquire Melt Pharmaceuticals Source: Not Specified

Financials
	TTM	Q2 2025	Q1 2025
Basic EPS	$.03	$.14	$-.5
Diluted EPS	$.03	$.13	$-.5
Revenue	$71.64M	$63.74M	$47.83M
Gross Profit	$53.93M	$47.51M	$32.31M
Net Income / Loss	$1.02M	$5M	$-17.78M
Operating Income / Loss	$14.75M	$11.41M	$-11.23M
Cost of Revenue	$17.71M	$16.23M	$15.52M
Net Cash Flow	$21.33M	$-13.76M	$19.48M
PE Ratio	1,766.67

Splits
Feb 08, 2013	1:5